中文名 | T5601640 |
英文名 | T56-LIMKi |
别名 | T5601640游离态 化合物T56-LIMKI LIMK2抑制剂(T56-LIMKI) 3-甲基-N-(3-((3-(三氟甲基)苯基)氨基甲酰基)苯基)异恶唑-5-甲酰胺 |
英文别名 | T5601640 T 5601640 T56-LIMKI T56-LIMKi T-5601640(T56-LIMKi) T56-LIMKi - T5601640 3-methyl-N-[3-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-1,2-oxazole-5-carboxamide 3-Methyl-N-[3-[[[3-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-5-isoxazolecarboxamide 5-Isoxazolecarboxamide, 3-methyl-N-[3-[[[3-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]- |
CAS | 924473-59-6 |
EINECS | 604-604-1 |
化学式 | C19H14F3N3O3 |
分子量 | 389.33 |
密度 | 1.426±0.06 g/cm3(Predicted) |
沸点 | 403.4±45.0 °C(Predicted) |
溶解度 | DMSO : 36 mg/mL (92.47 mM) |
酸度系数 | 11.41±0.70(Predicted) |
存储条件 | 2-8°C |
外观 | 粉末 |
颜色 | white to beige |
体外研究 | T56-LIMKi efficiently inhibits the growth of ST88-14, U87, Panc-1 cells, A549 lung cancer cells with IC 50 values of 18.3, 7.4, 35.2 and 90 μM, respectively. T56-LIMKi decreases phosphorylated cofilin (p-cofilin) levels and thus inhibits growth of several cancerous cell lines, including those of pancreatic cancer, glioma and schwannoma. It blocks the phosphorylation of cofilin which leads to actin severance and inhibition of tumor cell migration, tumor cell growth, and anchorage-independent colony formation in soft agar. T56-LIMKi (10-50 μM) reduces p-cofilin in a dose-dependent manner in NF1 −/− MEFs with an IC 50 of 30 μM. Notably, the inhibitor does not affect the amounts of total cofil. 50μM T56-LIMKi causes a statistically significant reduction in the number of cells exhibiting stress fibers. |
体内研究 | T56-LIMKi can induce inhibition of cofilin phosphorylation and Panc-1 tumor shrinkage in vivo . Mice treated with T56-LIMKi (60 mg/kg) shows a significant decrease in tumor volume compared to control. |
危险品运输编号 | UN 2811 6.1 / PGIII |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.569 ml | 12.843 ml | 25.685 ml |
5 mM | 0.514 ml | 2.569 ml | 5.137 ml |
10 mM | 0.257 ml | 1.284 ml | 2.569 ml |
5 mM | 0.051 ml | 0.257 ml | 0.514 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!